Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Stock Performance
The company has a market capitalization of C$21.54 million and a P/E ratio of -12.66. The stock’s fifty day moving average price is C$2.00 and its 200-day moving average price is C$2.00. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Recommended Stories
- Five stocks we like better than Liberty Biopharma
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What is the S&P/TSX Index?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Health Care Stocks Explained: Why You Might Want to Invest
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
